abstract |
The present disclosure relates to heterocyclic compounds and methods which inhibit ATR kinase to treat or prevent cancer. Certain compounds disclosed herein may possess useful ATR kinase inhibiting activity, and may be used in the treatment or prophylaxis of a disease or condition in which ATR kinase plays an active role. |